• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    S

    Southern District Health Board

    EST. 2010
    219论文总数
    3,653引用总数

    The Southern District Health Board (Southern DHB) is a district health board with the focus on providing healthcare to an area covering the southern half of the South Island of New Zealand.

    论文量&引用量时间轴

    机构学者

    论文(219)

    年份
    起
    –
    止
    排序
    1‘Hot Debriefs’–Belief and Grief
    Clive Dreyer
    2026Emergency Medicine Australasia(2026)
    引用
    AI阅读
    加入学术空间
    2When Prediction is Redundant: Expert Judgement and the Added Value of Demand Forecasting in Emergency Department Planning
    Ali PoshtMashhadi, Abtin Ijadi Maghsoodi, Lincoln Christopher Wood

    Background/Objectives: Emergency department (ED) demand models often rely on time-of-day and calendar patterns, yet accurate models do not automatically change practice. We examined what a predictive model adds to the judgement of clinicians, operational managers, and analysts, and what affects whether its signal is used. Methods: We used a convergent mixed-methods design within the evaluation phase of a design-science programme in one district of Aotearoa New Zealand. Seven semi-structured interviews with clinical, operational, and analytical staff were analysed using reflexive thematic analysis with hybrid coding; the model was withheld until the second half of each interview, so participants first described demand from experience. Routine ED arrival data for 2017–2023 from the same district were analysed descriptively as unadjusted daily counts, and the strands were integrated in a joint display interpreted through the Theory of Swift, Even Flow (TSEF) and Normalisation Process Theory (NPT). Acuity was approximated by arrival by emergency transport, which marks resource intensity at arrival rather than clinical severity. Results: Thirty-seven codes formed four themes. Before seeing the model, participants in all role groups described the main demand patterns, including daily and weekly cycles, winter pressure, and doubts about event-related surges, and the descriptive data were consistent with these views; in unadjusted comparisons, event days were no busier than other days (342.7 vs. 351.4 mean daily presentations). Participants judged that the model mainly formalised what they already knew and located its potential value in a clear, timely signal that shows demand against a normal baseline and links to inpatient discharge as well as staffing, with equity monitoring and Māori data sovereignty built in from the start. Participants, especially those in operational roles, placed the main constraint in access block, which the arrival data did not measure. Conclusions: We propose predictive redundancy as an interpretive concept for this overlap: for the predictable, calendar-driven component of daily arrivals, a model may add little to what experienced staff already know, so its value shifts from discovery to standardisation. Forecast accuracy was not compared with expert forecasts, so this proposition needs quantitative testing. TSEF identifies what a forecast should target, and NPT explains whether staff will use it.

    2026Healthcare(2026)
    引用
    AI阅读
    加入学术空间
    3The Brain Tumor Segmentation (Brats-Mets) Challenge 2023: Brain Metastasis Segmentation on Pre-treatment MRI
    Ahmed W Moawad,Anastasia Janas,Ujjwal Baid,Divya Ramakrishnan,Rachit Saluja,Nader Ashraf,Nazanin Maleki,Leon Jekel,Nikolay Yordanov, Pascal Fehringer,Athanasios Gkampenis,Raisa Amiruddin,

    The translation of AI-generated brain metastases (BM) segmentation into clinical practice relies heavily on diverse, high-quality annotated medical imaging datasets. The BraTS-METS 2023 challenge has gained momentum for testing and benchmarking algorithms using rigorously annotated internationally compiled real-world datasets. This study presents the results of the segmentation challenge and characterizes the challenging cases that impacted the performance of the winning algorithms. Untreated brain metastases on standard anatomic MRI sequences (T1, T2, FLAIR, T1PG) from eight contributed international datasets were annotated in stepwise method: published UNET algorithms, student, neuroradiologist, final approver neuroradiologist. Segmentations were ranked based on lesion-wise Dice and Hausdorff distance (HD95) scores. False positives (FP) and false negatives (FN) were rigorously penalized, receiving a score of 0 for Dice and a fixed penalty of 374 for HD95. The mean scores for the teams were calculated. Eight datasets comprising 1303 studies were annotated, with 402 studies (3076 lesions) released on Synapse as publicly available datasets to challenge competitors. Additionally, 31 studies (139 lesions) were held out for validation, and 59 studies (218 lesions) were used for testing. Segmentation accuracy was measured as rank across subjects, with the winning team achieving a LesionWise mean score of 7.9. The Dice score for the winning team was 0.65 ± 0.25. Common errors among the leading teams included false negatives for small lesions and misregistration of masks in space. The Dice scores and lesion detection rates of all algorithms diminished with decreasing tumor size, particularly for tumors smaller than 100 mm3. In conclusion, algorithms for BM segmentation require further refinement to balance high sensitivity in lesion detection with the minimization of false positives and negatives. The BraTS-METS 2023 challenge successfully curated well- annotated, diverse datasets and identified common errors, facilitating the translation of BM segmentation across varied environments and providing the tools for future development of personalized volumetric reports to patients undergoing BM treatment.

    2024ArXiv(2024)引用:32
    引用
    AI阅读
    加入学术空间
    4An Update of Post-Stroke Depression and the Use of Selective Serotonin Reuptake Inhibitors in Post-Stroke Recovery
    Siew Kwaon Lui, Minh Hoai Nguyen,Nguyễn Ngọc Hà, Tuong Hoa Anh, Donghu Zhen,Dung Nguyen, Edward Yi Chang, Consultant Geriatrician,D. Tan, Changjun Zhen

    Advancements in acute stroke management have led to improved mortality rates. However, stroke remains a chronic lifelong condition and is one of the top three leading causes of disability in Singapore. Stroke management typically commences in an acute hospital for acute stabilisation, followed by inpatient rehabilitation and outpatient rehabilitation. With the trend towards early supported discharge of stroke patients, general practitioners (GPs) are crucial in providing comprehensive and evidence based post-stroke care, which includes treating associated cardiovascular comorbidities as well as preventing complications and optimising quality of life. This article aims to provide GPs with current evidence on the use of selective serotonin inhibitors (SSRIs) in post-stroke recovery. It is important for GPs to be aware that post-stroke depression (PSD) is a common complication of stroke and significantly affects mortality and recovery. SSRIs have been commonly used for treatment of PSD. Early phase studies had suggested improvement of post-stroke motor outcomes with the use of SSRIs, although subsequent trials demonstrated conflicting results.

    2024The Singapore Family Physician(2024)
    引用
    AI阅读
    加入学术空间
    5Increased Expression of the Δ133p53β Isoform Enhances Brain Metastasis
    Ahmad Taha,David Wang, Paulomi M. M. Mehta,Sunali Mehta,Ashley Reily-Bell,Fouzia Ziad,Ziad Thotathil,Peter Y. C. Gan,Janice Royds,Antony Braithwaite,Noelyn Hung,Tania L. L. Slatter

    The Δ133p53β isoform is increased in many primary tumors and has many tumor-promoting properties that contribute to increased proliferation, migration and inflammation. Here we investigated whether Δ133p53β contributed to some of the most aggressive tumors that had metastasized to the brain. Δ133p53β mRNA expression was measured in lung, breast, melanoma, colorectal metastases and, where available, the matched primary tumor. The presence of Δ133p53β expression was associated with the time for the primary tumor to metastasize and overall survival once the tumor was detected in the brain. Δ133p53β was present in over 50% of lung, breast, melanoma and colorectal metastases to the brain. It was also increased in the brain metastases compared with the matched primary tumor. Brain metastases with Δ133p53β expressed were associated with a reduced time for the primary tumor to metastasize to the brain compared with tumors with no Δ133p53β expression. In-vitro-based analyses in Δ133p53β-expressing cells showed increased cancer-promoting proteins on the cell surface and increased downstream p-AKT and p-MAPK signaling. Δ133p53β-expressing cells also invaded more readily across a mock blood–brain barrier. Together these data suggested that Δ133p53β contributes to brain metastases by making cells more likely to invade the brain.

    2023INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES(2023)引用:6
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 219 篇论文

    合作机构(100)

    奥塔哥大学合作论文 118
    奥克兰大学合作论文 26
    Canterbury District Health Board合作论文 20
    Auckland District Health Board合作论文 12
    Waikato District Health Board合作论文 11
    Capital and Coast District Health Board合作论文 10
    奥克兰理工大学合作论文 9
    怀卡托大学合作论文 7
    Counties Manukau District Health Board合作论文 7
    Waitemata District Health Board合作论文 7

    机构统计